Invitae Buys Developer of Online Family History Tool | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Invitae Buys Developer of Online Family History Tool

June 13, 2017
by David Raths
| Reprints
Cloud-based CancerGene Connect created at UT Southwestern Medical Center

Invitae Corp., a San Francisco-based genetic information company, has acquired Ommdom Inc., the developer of CancerGene Connect, a platform for collecting and managing genetic family histories.

Invitae said the acquisition, for approximately $6 million of its common stock, expands its suite of genome management offerings designed to help patients and clinicians use genetic information as part of mainstream medical care.

The technology behind CancerGene Connect was first created in the late 1990s at UT Southwestern Medical Center in Dallas, which developed an initial version of the tool that enabled clinicians to digitally run risk assessment algorithms that previously required time-intensive research calculations for each patient. Ommdom has an exclusive license from UT Southwestern to further develop and commercialize CancerGene Connect.

CancerGene Connect uses a cloud-based, mobile friendly patient interface to gather family history information prior to a clinician appointment. Once completed, analytics tools using research on hereditary risk analyze a patient's predisposition to disease and provide actionable analysis to inform therapeutic decisions, such as genetic testing or treatment approaches. In addition, the platform provides clinicians with the ability to look beyond the individual to understand trends across all their patients.

"We are extremely proud of the platform we've built with CancerGene Connect and the impact it has on improving care for patients," said Richard Burghardt, chief executive officer of Ommdom, in a prepared statement. "Although most frequently discussed in relation to cancer, family health history also has significant and growing importance in the prevention and management of heart, metabolic, neurological, and other diseases. Joining Invitae will broaden the reach of our technology, bringing its benefits to more clinicians and their patients."

Invitae said its goal is to aggregate most of the world's genetic tests into a single service with higher quality, faster turnaround time, and lower price than many single-gene and panel tests today. The company provides a diagnostic service comprising approximately 1,500 genes for a variety of genetic disorders associated with oncology, cardiology, neurology, pediatrics, and other rare disease areas, as well as clinical analysis of a 20,000-gene medical exome.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

ONC Roundup: Senior Leadership Changes Spark Questions

The Office of the National Coordinator for Health IT (ONC) has continued to experience changes within its upper leadership, leading some folks to again ponder what the health IT agency’s role will be moving forward.

Media Report: Walmart Hires Former Humana Executive to Run Health Unit

Reigniting speculation that Walmart and insurer Humana are exploring ways to forge a closer partnership, Walmart Inc. has hired a Humana veteran to run its health care business, according to a report from Bloomberg.

Value-Based Care Shift Has Halted, Study Finds

A new study of 451 physicians and health plan executives suggests that progress toward value-based care has stalled. In fact, it may have even taken a step backward over the past year, the research revealed.

Study: EHRs Tied with Lower Hospital Mortality, But Only After Systems Have Matured

Over the past decade, there has been significant national investment in electronic health record (EHR) systems at U.S. hospitals, which was expected to result in improved quality and efficiency of care. However, evidence linking EHR adoption to better care is mixed, according to medical researchers.

Nursing Notes Can Help Predict ICU Survival, Study Finds

Researchers at the University of Waterloo in Ontario have found that sentiments in healthcare providers’ nursing notes can be good indicators of whether intensive care unit (ICU) patients will survive.

Health Catalyst Completes Acquisition of HIE Technology Company Medicity

Salt Lake City-based Health Catalyst, a data analytics company, has completed its acquisition of Medicity, a developer of health information exchange (HIE) technology, and the deal adds data exchange capabilities to Health Catalyst’s data, analytics and decision support solutions.